Winner Medical Co., Ltd. (300888.SZ)
CNY 40.96
(0.1%)
CNY 40.96
(0.1%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.43 Billion CNY | -7.99% |
| 2022 | 1.55 Billion CNY | -2.41% |
| 2021 | 1.59 Billion CNY | 31.31% |
| 2020 | 1.21 Billion CNY | 22.58% |
| 2019 | 992.41 Million CNY | 17.71% |
| 2018 | 843.06 Million CNY | 10.62% |
| 2017 | 762.11 Million CNY | 74.77% |
| 2016 | 436.06 Million CNY | 47.91% |
| 2015 | 294.82 Million CNY | 23.29% |
| 2014 | 239.13 Million CNY | 7.65% |
| 2013 | 222.15 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 1.45 Billion CNY | -0.52% |
| 2024 Q3 | 1.98 Billion CNY | 36.79% |
| 2024 Q1 | 1.46 Billion CNY | 1.85% |
| 2023 Q3 | 1.46 Billion CNY | 3.65% |
| 2023 FY | 1.43 Billion CNY | -7.99% |
| 2023 Q4 | 1.43 Billion CNY | -2.11% |
| 2023 Q1 | 1.45 Billion CNY | -6.5% |
| 2023 Q2 | 1.41 Billion CNY | -3.02% |
| 2022 Q3 | 1.88 Billion CNY | 4.12% |
| 2022 Q1 | 1.64 Billion CNY | 2.87% |
| 2022 FY | 1.55 Billion CNY | -2.41% |
| 2022 Q4 | 1.55 Billion CNY | -17.23% |
| 2022 Q2 | 1.8 Billion CNY | 10.1% |
| 2021 Q4 | 1.59 Billion CNY | 13.46% |
| 2021 Q2 | 1.26 Billion CNY | -4.72% |
| 2021 Q1 | 1.32 Billion CNY | 9.1% |
| 2021 FY | 1.59 Billion CNY | 31.31% |
| 2021 Q3 | 1.4 Billion CNY | 11.35% |
| 2020 Q3 | 1.27 Billion CNY | -1.34% |
| 2020 FY | 1.21 Billion CNY | 22.58% |
| 2020 Q2 | 1.29 Billion CNY | 0.0% |
| 2020 Q4 | 1.21 Billion CNY | -4.79% |
| 2020 Q1 | - CNY | -100.0% |
| 2019 Q1 | 785.77 Million CNY | 0.0% |
| 2019 FY | 992.41 Million CNY | 17.71% |
| 2019 Q4 | 992.41 Million CNY | 0.0% |
| 2019 Q2 | 785.77 Million CNY | 0.0% |
| 2018 FY | 843.06 Million CNY | 10.62% |
| 2017 FY | 762.11 Million CNY | 74.77% |
| 2016 FY | 436.06 Million CNY | 47.91% |
| 2015 FY | 294.82 Million CNY | 23.29% |
| 2014 FY | 239.13 Million CNY | 7.65% |
| 2013 FY | 222.15 Million CNY | 0.0% |